Clinical Trials Logo

Clinical Trial Summary

Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease


Clinical Trial Description

The purpose of this study is to investigate the phenomenon of cardiovascular system response to maternal hyperoxygenation in the fetus with congenital heart disease(CHD), which can provide further insight into fetal adaptations to CHD and improve our understanding of the pathophysiology of these conditions.Cases are gravidas with fetal congenital heart disease diagnosed by echocardiography various gestational weeks.The baseline fetal echocardiography parameters has obtained from these gravidas.Then the participants received 10-15 minutes hyperoxygenation, and the accordingly fetal echocardiography parameters were obtained.The objective of the study includes:(1)To investigate the response of the MCA PI to maternal hyperoxygenation in various forms of CHD. Middle cerebral artery(MCA) pulsatility index (PI) at MH will be compared to baseline at various gestational ages in a variety of types of CHD;(2)To investigate the response of the umbilical artery (UA) PI to maternal hyperoxygenation in various forms of CHD. UA PI at MH will be compared to baseline at various gestational ages in a variety of CHD; (3)To study the response of myocardial diastolic function to MH in various forms of CHD. Diastolic inflow patterns across the tricuspid and mitral valves will be measured and ductus venosus flow pattern will be evaluated at MH and compared to baseline at various gestational ages in a variety of CHD;(4)To investigate for any changes in cardiac output and the ratio of flow between the right and left ventricles in response to MH in various forms of CHD;(5)To investigate for changes in flow pattern at the aortic isthmus in those with suspicion or clear evidence of coarctation of the aorta. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03147014
Study type Interventional
Source Beijing Anzhen Hospital
Contact Yanping Ruan, MD
Phone +86 15311258732
Email yanping.ruan@163.com
Status Recruiting
Phase N/A
Start date January 1, 2016
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT01215240 - Prophylactic Peritoneal Dialysis Decreases Time to Achieve a Negative Fluid Balance After the Norwood Procedure N/A
Completed NCT00513240 - Erythropoetin Neuroprotection for Neonatal Cardiac Surgery Phase 1/Phase 2
Withdrawn NCT00156455 - Sleep Disordered Breathing in Children With Single Ventricle Physiology N/A
Terminated NCT01445041 - Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome Phase 1
Recruiting NCT04581668 - Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease N/A
Completed NCT01736956 - Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome N/A
Completed NCT01708863 - A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical Palliation
Recruiting NCT03406884 - The CHILD Trial: Hypoplastic Left Heart Syndrome Study. Phase 1
Active, not recruiting NCT03079401 - Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle Phase 1/Phase 2
Completed NCT02306057 - Fluid Balance in Children Undergoing Fontan Surgery N/A
Terminated NCT01107990 - Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
Completed NCT01883076 - Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome Phase 1
Completed NCT04056416 - Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike) N/A
Completed NCT01656941 - Genetic Determinants of Congenital Heart Disease Outcomes
Completed NCT00464100 - Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes
Active, not recruiting NCT03779711 - Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome Phase 2
Recruiting NCT04925024 - Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial. Phase 2
Recruiting NCT02781922 - Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial) Phase 3
Completed NCT01582529 - SVRII Family Factors Study
Completed NCT00974025 - Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients N/A